(Q36082068)

12 August 2017

1 reference

title

Cinacalcet HCl: a novel therapeutic for hyperparathyroidism (English)

1 reference

12 August 2017

1 reference

Angel L M de Francisco

series ordinal

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

441-452

1 reference

Morphology of osteoclasts in resorbing fetal rat bone explants: Effects of PTH and AIF in vitro

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Effects of parathyroid hormone on cytosolic free calcium concentration in individual rabbit connecting tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Parathyroid hormone gene expression in hypophosphatemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Parathyroidectomy in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

"Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Long-term fracture risk following renal transplantation: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.3.441

21 January 2018

Identifiers

DOI

10.1517/14656566.6.3.441

1 reference

release_mragayglgzavxnedocwkzte4tq

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mragayglgzavxnedocwkzte4tq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference